U.S. Physical Therapy (USPH) Projected to Post Quarterly Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Wednesday, May 7th. Analysts expect U.S. Physical Therapy to post earnings of $0.46 per share and revenue of $176.78 million for the quarter.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock traded up $1.08 during mid-day trading on Friday, reaching $72.43. The company's stock had a trading volume of 102,686 shares, compared to its average volume of 108,028. The firm's fifty day moving average price is $73.14 and its two-hundred day moving average price is $84.08. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $108.14. The company has a market capitalization of $1.10 billion, a P/E ratio of 77.05, a PEG ratio of 3.54 and a beta of 1.44.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.49%. U.S. Physical Therapy's payout ratio is 97.83%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. JMP Securities restated a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Finally, Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.